BioXcel Therapeutics Inc (NASDAQ: BTAI) Could Achieve Gains In The Near Future

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

BioXcel Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of BioXcel Therapeutics Inc is $24.56M. A total of 0.77 million shares were traded on the day, compared to an average of 617.75K shares.

In the most recent transaction, Yocca Frank sold 355 shares of BTAI for 0.69 per share on Sep 16 ’24. After the transaction, the Chief Scientific Officer now owns 14,203 company shares. In a previous transaction on Sep 16 ’24, Mehta Vimal sold 1,982 shares at 0.69 per share. BTAI shares that CEO and President owns now total 51,666.

Among the insiders who sold shares, Steinhart Richard I disposed of 356 shares on Sep 16 ’24 at a per-share price of $0.69. This resulted in the Chief Financial Officer holding 6,204 shares of BTAI after the transaction. In another insider transaction, Rodriguez Javier sold 345 shares at $0.69 per share on Sep 16 ’24. Company shares held by the insider now total 9,133.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, BTAI has a high of $5.62 and a low of $0.50.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BTAI’s latest balance sheet shows that the firm has $232.97M in Cash & Short Term Investments as of fiscal 2021. There were $1.10M in debt and $16.67M in liabilities at the time. Its Book Value Per Share was -$1.84, while its Total Shareholder’s Equity was $221.67M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BTAI is Buy with a score of 4.00.

Most Popular

Related Posts